TUESDAY, MAY 10
| 09:00 - 09:15 | Welcome by Conference Chairpersons: |
| Ruti Alon, Founder and CEO, Medstrada | |
| Ora Dar, PhD, Senior Expert, Medical Sciences and Health Innovation | |
| Nissim Darvish, MD, PhD, Managing General Partner, MeOHR Ventures | |
| 09:15 - 09:30 | Coffee Break |
| HALL A | |
| 09:30 - 14:00 | CELL, GENE AND NUCLEIC ACIDS THERAPIES - THE NEXT FRONTIER IN HUMAN HEALTH |
| 11:00 - 11:30 | Coffee Break |
| Chairpersons: Erez Chimovits, Orbimed Partner, Private Equity, Rami Skaliter, PhD, CEO, Cell Cure Neurosciences | |
| 09:30 - 09:40 | Opening Remarks: Erez Chimovits, Orbimed Partner, Private Equity |
| 09:40 - 10:00 | Sumant Ramachandra, MD, PhD, President and CEO, ImmPACT Bio, "Autologous CAR-T based therapies," "ZOOM" |
| 10:00 - 10:20 | Chen Schor, President and CEO, Adicet Bio, "Allogeneic CAR-T based therapies" |
| 10:20-10:35 | Noam Pilpel, PhD, CTO, Gilboa Therapeutics |
| 10:35 - 10:55 | Zhen Li, PhD, President and CEO, ADARx Pharmaceuticals, "Oligonucleotide therapeutics" |
| 11:30 - 11:45 | Gili Hart, CEO, Splisense |
| 11:45 - 12:05 | Adel Nada, MD, Co-founder and CEO, GentiBio, "T-regs for curing autoimmunity" |
| 12:05 - 12:25 | David Baram, PhD, President and CEO, Emendo Biotherapeutics, "Gene editing based therapies" |
| 12:25 - 12:45 | Michal Golan Mashiach, PhD, Founder and CEO, EdiTy Therapeutics |
| 12:45 - 13:00 | Rami Skaliter, PhD, CEO, Cell Cure Neurosciences, "Embrionic stem cells therapies" |
| 13:00 - 13:15 | Yona Geffen, PhD, VP, R&D, Gamida Cell |
| 13:15 - 13:30 | Noam Diamant, PhD, Co-founder and CEO, Noga Therapeutics |
| 13:30 - 13:45 | Adi Elkeles, PhD, Founder and CEO, Trobix Bio |
| 13:45 - 14:00 | Prof. Dror Mevorach, MD, CSO, Enlivex Therapeutics, "Allocetra-OTS: High synergistic effectiveness against solid tumor with immune check point inhibitors or CAR T." |
| 14:00 - 15:00 | Lunch Break |
| HALL B | |
| 09:30 - 14:00 | MEDICAL DEVICE - BREAKTHROUGH TECHNOLOGIES |
| 11:00 - 11:30 | Coffee Break |
| Chairperson: Eyal Lifschitz, Co-founder and General Managing Partner, Peregrine Ventures |
|
| 09:30 - 09:45 | David Rigler, VP Clinical Research and Regulatory Affairs, Nano Retina |
| 09:45 - 10:00 | Ronen Eckhouse, Co-founder and CEO, Rapid Medical |
| 10:00 - 10:15 | Amir Danino, Founder and CEO, Innoventric |
| 10:15 - 10:30 | Shlomit Chappel-Ram, PhD, VP, R&D, Digma Medical |
| 10:30 - 10:45 | Yotam Drechsler, CEO and Co-founder, BrainQ Technologies |
| 10:45 - 11:05 | Daniel Goldstein, PhD, Advocate and Patent Attorney, Sanford T. Colb & Co., "Ecosystems and homeostasis: A law and technology look at the field of medical devices" |
| 11:30 - 11:45 | Ronen Segal, CTO, Alpha Tau Medical |
| 11:45 - 12:00 | Avner Geva, Founder and CEO, Vensica Therapeutics |
| 12:00 - 12:15 | Idan Geva, CEO, |
| 12:15 - 12:35 | Joseph (Joe) Smith, MD, PhD, CSO, Becton Dickinson, "BD - Innovation at Scale" |
| 12:35 - 12:50 | Benny Dilmoney, CEO, Magneto Thrombectomy Solutions |
| 12:50 - 13:05 | Gilad Marom, CEO, Restore Medical |
| 13:05 - 13:20 | Dvir Cohen, CEO and President, Memic Innovative Surgery |
| 13:20 - 13:30 | Closing Remarks: Eyal Lifschitz, Co-founder and General Managing Partner, Peregrine Ventures |
| 13:30 - 13:50 | Sandra Morgan, Board Director and Advisor, Healthcare, Pharmaceutical, and Technology, "MedTech 2032: The Future" |
| 14:00 - 15:00 | Lunch Break |
| HALL C | |
| 09:30-14:00 | BIO FOOD - NEW ERA OF FOOD TECHNOLOGIES; ITS IMPACT ON NUTRITION AND HEALTH |
| 11:00 - 11:30 | Coffee Break |
| Chairperson: Tammy Meiron, PhD, CTO, Fresh Start FoodTech Incubator | |
| 09:30 - 09:55 | Valerio Nanninni, General Manager, Novozymes Advanced Proteins Solutions, "The food industry perspective and the adaptation of bio-tech technologies" |
| 09:55 - 10:20 | Matthew Robin, CEO, Mifloma Group-at Migros Industries, "The perspective of a leading FoodTech company, entering the Bio Food arena" |
| 10:20 - 10:45 | Prof. Yaakov Nahmais, PhD, Founder and President, Future Meat Technologies, "The evolution of a Bio Food Company in the eye of an academic researcher" |
| 10:45 - 11:00 | Ilan Samish, Phd, Founder and CEO, Amai Proteins |
| 11:30 - 11:55 | Prof. Eldad Tzahor, PhD, Co-founder and scientific advisor, Profuse Tech, "Bioconversion - the Case Study of Profuse" |
| 11:55 - 12:20 | Miriam Guggenheim, Co-chair, Covington’s Israel International Initiative, "Regulatory barriers and challenges in adaptation of bio-tech platforms into foods" |
| 12:20 - 12:35 | Tal Lutzky, Co-founder and CEO, Pigmentum |
| 12:35 - 12:50 | Neta Lavon, PhD, CTO, Aleph Farm |
| 12:50 - 13:05 | Orna Harel, PhD, Co-founder and CEO, Sea 2 Cell |
| 13:05 - 13:20 | Tsipi Shoham, PhD, Co-founder and CEO, GreenOnyx |
| 13:20 - 13:35 | Iftach Nachman, PhD, Co-founder and Scientific Advisor, Forsea |
| 13:35 - 13:50 | Fabian Trumper, Co-founder and CEO, Bountica |
| 13:50 - 14:05 | Prof. Nurit Argov-Argaman, PhD, CTO, Wilk |
| 14:00 - 15:00 | Lunch Break |
| PLENARY SESSION | |
| 15:15 - 15:45 | Mikael Dolsten, MD, PhD, Chief Scientific Officer and President, "ZOOM" Fireside Chat with: Gil Bar-Nahum, PhD, Managing Director, Jefferies International, UK |
| 15:45 - 16:15 | Robert Cohen, MS, President, Digital, Robotics, and Enabling Technology, Stryker, "Orthopedic industry and clinical insights - AI and predictive analytics," "ZOOM" |
| 16:15 - 16:45 | Gil Bar-Nahum, PhD, Managing Director, Jefferies International, UK, "The State of Life Sciences Industry, Today and Tomorrow" |
| 16:45 - 17:15 | Sandra Morgan, Board Director and Advisor, Healthcare, Pharmaceutical, and Technology, "Trials and Tribulations on the Riad to Marketing and Selling your Products to the USA Healthcare System" |
| 17:30 - 20:00 | Gala Event |
